The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a exciting development. Unlike injections, this approach offers a less invasive way to provide GLP-1 medications. https://liviamcpe459770.anchor-blog.com/21383603/glp-1-patches-a-novel-approach-to-blood-sugar-control